Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.595 USD | +2.66% | +11.07% | -27.86% |
May. 14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Syros Pharmaceuticals, Inc. Agrees to Amend Its Loan Agreement with Oxford Finance LLC | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.86% | 146M | |
+39.54% | 50.93B | |
-0.29% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+13.16% | 26.02B | |
-22.33% | 18.9B | |
+8.20% | 13.21B | |
+24.14% | 12.17B | |
+30.15% | 12.16B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Syros Gets Fast Track Label For Tamibarotene to Treat Acute Myeloid Leukemia; Shares Rise